logo
Plus   Neg
Share
Email

Teva Pharmaceutical Industries Limited Q1 adjusted earnings Beat Estimates

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: $69 million in Q1 vs. -$105 million in the same period last year.
-EPS: $0.06 in Q1 vs. -$0.10 in the same period last year.
-Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $835 million or $0.76 per share for the period.
-Analysts projected $0.59 per share
-Revenue: $4.36 billion in Q1 vs. $4.15 billion in the same period last year.

-Guidance:
Full year EPS guidance: $2.30 - $2.55
Full year revenue guidance: $16.6 - $17 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT